Literature DB >> 19697412

Syndrome surveillance and molecular epidemiology for early detection and tracing of an outbreak of measles in Liguria, Italy.

Filippo Ansaldi1, Andrea Orsi, Fiorella Altomonte, Giuseppe Bertone, Valentina Parodi, Roberto Carloni, Paolo Moscatelli, Ermanno Pasero, Marco Comaschi, Paola Oreste, Giovanni Orengo, Paolo Durando, Giancarlo Icardi.   

Abstract

The performances of surveillance systems for measles in Europe are poorly investigated, despite the fundamental role they should play in the early detection of outbreaks and in the assessment of the progress towards elimination. A new chief complaint syndrome surveillance system has been developed in Genoa, Italy, using data from the Emergency Department records of the regional reference university hospital and its ability to early detect an outbreak of measles that began during the winter months of 2007/2008 was evaluated. For the 23-month period from January 2007 to November 2008, the Emergency Department registration and triage software was used to obtain the time series of daily counts, that were related with cases notified by the statutory notification system and detection and characterization data from the measles regional reference laboratory. One hundred fifty five cases of measles-like illness were identified by the syndrome surveillance system. Two epidemic threshold breakthroughs were able to anticipate the first notified case by 54 and 11 days. Globally, the new syndrome surveillance system allows the activation of the alert state with a specificity of 94.3% and a sensitivity of 91%. Molecular investigation showed the spread of the virus from United Kingdom to Piemonte and then to Liguria and allowed us to exclude the re- circulation of strains circulating in Northern Italy during the previous seasons. Syndrome surveillance integrated with a rapid detection and characterization of the agent responsible for the disease could be an effective, specific and sensitive tool for measles surveillance.

Mesh:

Substances:

Year:  2009        PMID: 19697412     DOI: 10.1002/jmv.21584

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults.

Authors:  Filippo Ansaldi; Andrea Orsi; Cecilia Trucchi; Daniela De Florentiis; Antonella Ceravolo; Martina Coppelli; Sergio Schiaffino; Valter Turello; Roberto Rosselli; Roberto Carloni; Giancarlo Icardi; Ligurian Pneumococcal Study Group; Paola Canepa; Laura Sticchi; Roberta Zanetti; Ilaria Cremonesi; PierClaudio Brasesco; Paolo Moscatelli
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

2.  Performance Evaluation of the VIDAS(®) Measles IgG Assay and Its Diagnostic Value for Measuring IgG Antibody Avidity in Measles Virus Infection.

Authors:  Julia Dina; Christian Creveuil; Stephanie Gouarin; Florent Viron; Amelie Hebert; Francois Freymuth; Astrid Vabret
Journal:  Viruses       Date:  2016-08-20       Impact factor: 5.048

3.  Hospital and economic burden of influenza-like illness and lower respiratory tract infection in adults ≥50 years-old.

Authors:  Cecilia Trucchi; Chiara Paganino; Andrea Orsi; Daniela Amicizia; Valentino Tisa; Maria Francesca Piazza; Domenico Gallo; Simona Simonetti; Bruno Buonopane; Giancarlo Icardi; Filippo Ansaldi
Journal:  BMC Health Serv Res       Date:  2019-08-19       Impact factor: 2.655

4.  Emergency department syndromic surveillance systems: a systematic review.

Authors:  Helen E Hughes; Obaghe Edeghere; Sarah J O'Brien; Roberto Vivancos; Alex J Elliot
Journal:  BMC Public Health       Date:  2020-12-09       Impact factor: 3.295

5.  Success Factors of European Syndromic Surveillance Systems: A Worked Example of Applying Qualitative Comparative Analysis.

Authors:  Alexandra Ziemann; Anne Fouillet; Helmut Brand; Thomas Krafft
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

6.  Lowering the recommended age for the free and active offer of influenza vaccination in Italy: clinical and economic impact analysis in the Liguria region.

Authors:  Cecilia Trucchi; Marco D'Amelio; Daniela Amicizia; Andrea Orsi; Idalba Loiacono; Roberta Tosatto; Maria Francesca Piazza; Chiara Paganino; Andrea Pitrelli; Giancarlo Icardi; Filippo Ansaldi
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.